Oral Controlled Release Drug Delivery Technology Market Outlook (2022 to 2032)
[222 Pages Report] The global oral controlled release drug delivery technology market is poised to grow from US$ 34.1 billion in 2022 to US$ 68.4 billion by 2032, with overall demand expected to surge at 7.2% CAGR throughout the forecast period (2022 to 2032). The rising incidence of chronic diseases coupled with a growing preference for oral drug delivery due to its various benefits is the key factor driving demand for oral controlled-release drug delivery technology.
Based on form, the solid dosage forms segment is expected to lead the global oral controlled release drug delivery technology market throughout the forecast period with an estimated share of nearly 87%.
Attribute
Key Statistics
Oral Controlled Release Drug Delivery Technology Market Base Value (2021)
US$ 31.8 billion
Estimated Market Value (2022)
US$ 34.1 billion
Projected Market Value (2032)
US$ 68.4 billion
Value-based CAGR (2022 to 2032)
7.2%
Market share of Top 5 countries
62.1%
The oral controlled release drug delivery system is designed to deliver a drug in a controlled and predictable manner over a period of time or at a predetermined position in the gastrointestinal tract. Oral dosage forms are preferred for their convenience and cost-effectiveness.
Oral controlled release drug delivery technologies like, Geolock, Geomatrix, OROS (osmotic-controlled release drug delivery system), SODAS (Spheroidal oral drug absorption system), and many more are exclusively used for most of the pharmaceutical drug candidates and are the most common form to deliver medication to patients.
Oral solid dosage forms coupled with new drug releases mechanisms such as dissolution and diffusion-controlled drug release delivery systems are expected to remain a mainstay in the global pharmaceuticals market as these type of new and enhanced drug delivery systems with the use of advanced polymers tend to be an important part of drug development technology and approvals of new chemical entities.
The overall oral controlled release drug delivery technology market formed nearly 14% of the global pharmaceutical drug delivery market which was valued at around US$ 230 billion in 2021
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales Analyses of Oral Controlled Release Drug Delivery Technology Market 2012 to 2021 Vs Market outlook for 2022 to 2032.
Sales in the oral controlled release drug delivery technology market are projected to rise at 7.2% CAGR during the forecast period between 2022 to 2032, in comparison to 6.5% CAGR registered from 2012 to 2021.
Growing demand for specialized oral dosage forms such as pediatric or geriatric tablets with controlled release drug delivery systems, the adoption rate of newly developed and innovative technologies such as nanotechnology, osmotically controlled release, hydrophilic ion exchange, etc. are the prime factors expected to drive the growth of oral controlled release drug delivery technology market over the forecast period.
Oral drug delivery has become the most preferred and convenient option as the oral route provides maximum active surface area among all drug delivery systems for the administration of various drugs.
Increasing generic penetration is another important factor pushing the growth of the global market. Oral solid dosage forms such as tablets and capsules represent the largest growth opportunity for generic players.
Some other factors influencing the growth of the global oral controlled release drug delivery technology market include cost-effective generic dosage forms, Research and Development (R&D) scientists, and healthcare professionals’ preference for sustained release controlled delivery coupled with new biopolymers embedded with advanced coating technology in solid dosage forms, liquids, and semisolids.
Furthermore, the combination of various technologies to overcome the limitations of poorly soluble substances/drugs/chemicals and the higher adoption rate of these combined products/technologies at convenient pricing is expected to boost the oral controlled release drug delivery technology market.
In addition to this, increasing approval of modified and extended-release oral dosage forms by various health ministries across the world is likely to drive the market.
What are the Key Trends Driving the Global Oral Controlled Release Drug Delivery Technology Market?
The rise in Chronic Diseases and Advancement in Drug Delivery Techniques to Boost Market Growth
As per FMI, the global oral controlled release drug delivery technology market is projected to expand at a robust pace during the forecast period, owing to the rising prevalence of chronic and infectious diseases like cancer, T.B. heart disease, diabetes, etc., and increasing spending on oral medications.
Similarly, continuous efforts of manufacturers to develop and produce novel complex drug products with customized release trends will propel the expansion of the oral controlled release drug delivery technology market globally during the forecast years.
Use of combination techniques such as modified controlled release mechanisms and other platforms which uses ion exchange release (hydrophilic & hydrophobic), osmotically controlled release, diffusion & dissolution (combined) controlled release in new drug formulation procedures is on the rise across the healthcare industry and the trend is likely to continue during the forecast period.
Also, the introduction of super generics, continuous new technology launches, and a growing number of contract manufacturing facilities for oral solid dosage forms & liquid dosage forms, and enhanced patient compliance are expected to create lucrative market growth opportunities during the forecast period.
According to research published in the Journal of Controlled Release, it has been found that ‘casein’ based formulations are probable contenders for controlled release drug delivery systems, because of their properties like high tensile strength and presence of naturally occurring genipin, tissue enzyme & transglutaminase. Casein can also be used as a cross-linkers to prepare novel casein-based hydrogels for the controlled release of bioactive.
Similarly, the growing usage of 3D printing technology for designing and manufacturing oral formulations is expected to create lucrative opportunities for oral controlled-release drug delivery system manufacturers.
3D printing techniques can be used to produce multiple doses of drugs at a small scale and to improve drug formulations. 3D printing technology can be a great prospect for manufacturers to impose in their innovative, research and development department for drug formulations.
Find your sweet spots for generating winning opportunities in this market.
What are Factors Restraining the Growth in Oral Controlled Release Drug Delivery Technology Market?
Formulation challenges are mainly drug-related - active pharmaceutical ingredients with a short half-life and the necessity for higher-dose delivery and formulation related, which regularly require dissolvable handling capacities in light of the fact that most polymers should be solubilized in natural solvents before covering the controlled-release formulations (i.e., tablets, granules, and capsules)
Growing research towards biological molecules and their dominance in treating oncology conditions are expected to hamper the growth of the oral controlled release drug delivery technology market over the forecast period.
According to an article published in Contract pharma, approximately 50% of the pipeline molecules are biologics and the rest are in the form of other dosage forms.
However, the low pipeline productivity of oral solids is the major factor hindering the growth of the oral controlled-release drug delivery technology market.
Other factors include a complex supply chain and stringent regulatory requirements, decreasing productivity coupled with low R&D expenditure, product related issues such as dose dumping and product recalls.
Country Wise Insights
Why is the USA Leading Oral Controlled Release Drug Delivery Technology Market?
Rising Spending on Medicines Fuelling Market Growth in the USA
The USAoral controlled release drug delivery technology market reached a valuation ofover US$ 11.0 billion in 2021 and is expected to grow over a CAGR of 7.0% during the forecast period (2022 to 2032).
The rising prevalence of chronic diseases such as cancer and diabetes, supporting initiatives & campaigns from the government, and investments in research & development are driving b growth in the USA market and the trend is likely to continue during the forecast period.
Similarly, the strong presence of major key players in the country and their promotional strategies for the adoption of controlled release drug delivery systems are expected to expand the oral controlled release drug delivery technology market in the future.
In addition to this, increasing spending on medicines across the country will create opportunities for oral controlled-release drug delivery technology manufacturers in the future. In fact, the USA is the highest spending country worldwide when it comes to health care.
According to the USA Department of Health and Human Services, USA prescription drug expenditures totaled an enormous valuation of US$370 billion in 2019 and this number is likely to further surge during the assessment period.
What is the Demand Outlook in Germany Oral Controlled Release Drug Delivery Technology Market?
Rising Prevalence of Heart Diseases Driving Demand Across Germany
As of 2021, Germany held a revenue share of 21.5% of total European oral controlled release drug delivery technology market and it is estimated to grow at a healthy pace during the forecast period.
The German oral controlled release drug delivery technology market will likely be driven by improved patient compliance, rising geriatric and paediatric populations, and increased demand for controlled release drug delivery systems due to the prevalence of chronic diseases.
Over the years, there has been a sharp rise in cases of heart disease across Germany leading to a high death rate. Oral solid dosages are utilized very commonly for the treatment of the same. As per the World Health Organization (WHO) insights in 2019, nearly 37% of deaths in Germany were due to circulatory diseases.
Thus, the growing demand for oral solid dosage together with the rising prevalence of circulatory disease is expected to boost Germany’s oral controlled release drug delivery technology market during the next ten years.
Why is Japan Emerging as the Fastest Growing Oral Controlled Release Drug Delivery Technology Market?
Growing Preference for Oral Medication Fostering Market Growth in Japan
The overall oral controlled release drug delivery technology market in Japan reached US$ 2.6 billion in 2021 and it is expected to expand at a CAGR of around 6.7% during the forecast period. This can be attributed to the rising popularity of oral medication among the country’s rapidly growing population, advancements in the pharmaceutical sector, and increasing investments in R&D activities by biopharma companies.
Similarly, increasing healthcare spending and high levels of health awareness among the general public are expected to bolster the growth of the oral controlled release drug delivery technology market in Japan during the forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category Wise Insights
Which is the Most Popular Drug Release System in Oral Controlled Release Drug Delivery Technology Market?
Demand Remains High for Dissolution Controlled Release System
The dissolution controlled release system segment dominated the global oral controlled release drug delivery technology market with a revenue share of nearly 45% in 2021 and the trend is projected to continue throughout the forecast period.
Properties such as maximum efficacy with minimal side effects and reduced drug accumulation with drug level fluctuation are the major reasons for the adoption of this technique.
The dissolution controlled release system provides sustained release profiles i.e., In a dissolution controlled release system, the active drugs are released continuously at a slow rate to provide a long-term therapeutic effect. Thus, they provide a sustained release profile, which is encouraging their adoption across the world.
Which Dosage Form Remains Highly Preferred Among End Users?
End Users Prefer Solid Dosage Forms
As per FMI, the solid dosage forms segment generated revenue of around US$ 27 billion in the global oral controlled release drug delivery technology market in 2021 and it is poised to grow at a higher CAGR over the next ten years. This can be attributed to the rising end-user preference for solid dosage forms.
Owing to the better physical and chemical stability, lower manufacturing costs, and easy-to-consume & carry features of solid dosage forms, it remains highly popular among end users. People are increasingly opting for solid dosage forms like tablets, capsules, and powders to treat various diseases.
Competitive Landscape
Some of the key players identified in global oral controlled release drug delivery technology market are AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., and Johnson & Johnson.
These players are trying to combine new molecular entities with existing ones to explore clinical indications for controlled release mechanisms, which in turn is propelling the discovery of new matrix systems in the oral controlled release drug delivery technology market. Furthermore, they are partnering and collaborating with other companies to increase their revenue share. For instance,
In January 2020, Adare Pharmaceuticals Inc. collaborated with NLS pharmaceuticals and developed a product ‘Mazindol (MZD)’- A controlled release product, for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD).
In 2020, Bristol Myers Squibb announced the commercial launch and availability of ZEPOSIA®(ozanimod) 0.92 mg, a new once-daily oral medication for adults for the treatment of relapsing forms of multiple sclerosis (RMS).
In 2022, Sandoz, a Novartis division, acquired Coalesce Product Development Limited, the United Kingdom-based medical and drug delivery device development company.
Report Scope as per Oral Controlled Release Drug Delivery Technology Industry Analysis
Attribute
Details
Estimated Market Size (2022)
US$ 34.1 billion
Projected Market Size (2032)
US$ 68.4 billion
Anticipated Growth Rate (2022 to 2032)
7.2%
Forecast Period
2022 to 2032
Historical Data Available for
2012 to 2021
Market Analysis
US$ million for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA).
Key Countries Covered
USA, Canada, Brazil, Mexico, Argentina, the Rest of Latin America, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, the Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA.
Key Market Segments Covered
Drug Release System, Dosage Form, Region
Key Companies Profiled
AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., Johnson & Johnson, GlaxoSmithKline Plc., Sun Pharmaceuticals, Sanofi S.A., Boehringer Ingelheim, AbbVie, Takeda, Eli Lilly, Bayer, Gilead Sciences, Amgen, BioNTech, Viatris, Moderna.
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Key Market Segments Covered in the Oral Controlled Release Drug Delivery Technology Market Research
Drug Release System:
Dissolution Controlled Release System
Diffusion Controlled Release System
Osmotically Controlled Release System
Dissolution and Diffusion Controlled Release System
Ion Exchange Resins Controlled Release System
Hydro-dynamically Balanced Drug Delivery System
Others
Dosage Form:
Solid Dosage Forms
Semisolid/Liquid/Suspensions
Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
The global oral controlled release drug delivery technology market is estimated to be valued at US$ 34.1 billion in 2022.
The global oral controlled release drug delivery technology market is anticipated to reach a valuation of about US$ 68.4 billion by the end of 2032.
As per FMI, the global oral controlled release drug delivery technology market is expected to grow at around 7.2% CAGR during the forecast period.
North America will continue to dominate the global oral controlled release drug delivery technology, exhibiting a growth rate of 6.9% CAGR throughout the forecast period.
With a valuation of nearly US$ 27 Billion in 2021, the solid dosage forms segment will continue to lead the global oral controlled release drug delivery technology market.
AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., Johnson & Johnson, GlaxoSmithKline Plc., and Sun Pharmaceuticals are the major players operating in the global market.
Increasing adoption rates of the newer technologies, growing incidence of chronic diseases, increasing geriatric & paediatric population, and investments in research & development activities are some of the major factors driving the global oral controlled release drug delivery technology market.
Table of Content
1. Executive Summary | Oral Controlled Release Drug Delivery Technology Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, by Region
4.2. Key promotional strategies by manufacturers
4.3. Regulatory Landscape
4.4. Value chain analysis
4.5. Drug Release System adoption analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Complexity of Healthcare Operations
5.2.3. Drug Release System Pricing
5.2.4. Strategic Collaborations amongst Players
5.2.5. Rising Prevalence of Infections and Surgical Procedures
5.2.6. Adoption Rate
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID 002D19 and Impact Analysis
6.1.1. By Drug Release System
6.1.2. By Dosage Form
6.1.3. By Country
6.2. 2021 Market Scenario
7. Global Oral Controlled Release Drug Delivery Technology Market Demand (in Value) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ million) Analysis, 2012 to 2021
7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Drug Release System
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ million) Analysis, By Drug Release System, 2012 to 2021
8.3. Current and Future Market Size (US$ million) Analysis and Forecast, By Drug Release System, 2022 to 2032
8.3.1. Dissolution Controlled Release System
8.3.2. Diffusion Controlled Release System
8.3.3. Osmotically Controlled Release System
8.3.4. Dissolution & Diffusion Controlled Release System
8.3.5. Ion Exchange Resins Controlled Release
8.3.6. Hydrodynamically Balanced Drug Delivery System
8.3.7. Others
8.4. Market Attractiveness Analysis, by Drug Release System
9. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Dosage Form
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ million) Analysis, By Dosage Form, 2012 to 2021
9.3. Current and Future Market Size (US$ million) Analysis and Forecast, by Dosage Form, 2022 to 2032
9.3.1. Solid Dosage Form
9.3.2. Semisolid/Liquid/Suspensions
9.4. Market Attractiveness Analysis, by Dosage Form
10. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
10.1. Introduction
10.2. Historical Market Size (US$ million) Analysis, by Region, 2012 to 2021
10.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis, by Region
11. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032
11.1. Introduction
11.2. Historical Market Size (US$ million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021
11.3. Current and Future Market Value (US$ million) and Volume (Unit) Projections, 2022 to 2032
11.3.1. By Country
11.3.1.1. The USA
11.3.1.2. Canada
11.3.2. By Drug Release System
11.3.3. By Dosage Form
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Drug Release System
11.4.3. By Dosage Form
11.5. Market Trends
11.6. Drivers and Restraints - Impact Analysis
11.7. Country Level Analysis & Forecast
11.7.1. The USA Oral Controlled Release Drug Delivery Technology Market Analysis
11.7.1.1. Introduction
11.7.1.2. Market Analysis and Forecast, by Market Taxonomy
11.7.1.2.1. By Drug Release System
11.7.1.2.2. By Dosage Form
11.7.2. Canada Oral Controlled Release Drug Delivery Technology Market Analysis
11.7.2.1. Introduction
11.7.2.2. Market Analysis and Forecast, by Market Taxonomy
11.7.2.2.1. By Drug Release System
11.7.2.2.2. By Dosage Form
12. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021
12.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
12.3.1. By Country
12.3.1.1. Mexico
12.3.1.2. Brazil
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Drug Release System
12.3.3. By Dosage Form
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug Release System
12.4.3. By Dosage Form
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. Mexico Oral Controlled Release Drug Delivery Technology Market Analysis
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
12.7.1.2.1. By Drug Release System
12.7.1.2.2. By Dosage Form
12.7.2. Brazil Oral Controlled Release Drug Delivery Technology Market Analysis
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
12.7.2.2.1. By Drug Release System
12.7.2.2.2. By Dosage Form
12.7.3. Argentina Oral Controlled Release Drug Delivery Technology Market Analysis
12.7.3.1. Introduction
12.7.3.2. Market Analysis and Forecast, by Market Taxonomy
12.7.3.2.1. By Drug Release System
12.7.3.2.2. By Dosage Form
13. Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021
13.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Drug Release System
13.3.3. By Dosage Form
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug Release System
13.4.3. By Dosage Form
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. Germany Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
13.7.1.2.1. By Drug Release System
13.7.1.2.2. By Dosage Form
13.7.2. Italy Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
13.7.2.2.1. By Drug Release System
13.7.2.2.2. By Dosage Form
13.7.3. France Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
13.7.3.2.1. By Drug Release System
13.7.3.2.2. By Dosage Form
13.7.4. U.K. Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.4.1. Introduction
13.7.4.2. Market Analysis and Forecast, by Market Taxonomy
13.7.4.2.1. By Drug Release System
13.7.4.2.2. By Dosage Form
13.7.5. Spain Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.5.1. Introduction
13.7.5.2. Market Analysis and Forecast, by Market Taxonomy
13.7.5.2.1. By Drug Release System
13.7.5.2.2. By Dosage Form
13.7.6. BENELUX Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.6.1. Introduction
13.7.6.2. Market Analysis and Forecast, by Market Taxonomy
13.7.6.2.1. By Drug Release System
13.7.6.2.2. By Dosage Form
13.7.7. Russia Oral Controlled Release Drug Delivery Technology Market Analysis
13.7.7.1. Introduction
13.7.7.2. Market Analysis and Forecast, by Market Taxonomy
13.7.7.2.1. By Drug Release System
13.7.7.2.2. By Dosage Form
14. East Asia Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Distribution Channel (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Drug Release System
14.3.3. By Dosage Form
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug Release System
14.4.3. By Dosage Form
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. China Oral Controlled Release Drug Delivery Technology Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
14.7.1.2.1. By Drug Release System
14.7.1.2.2. By Dosage Form
14.7.2. Japan Oral Controlled Release Drug Delivery Technology Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
14.7.2.2.1. By Drug Release System
14.7.2.2.2. By Dosage Form
14.7.3. South Korea Oral Controlled Release Drug Delivery Technology Market Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
14.7.3.2.1. By Drug Release System
14.7.3.2.2. By Dosage Form
15. South Asia Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Drug Release System
15.3.3. By Dosage Form
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug Release System
15.4.3. By Dosage Form
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. India Oral Controlled Release Drug Delivery Technology Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
15.7.1.2.1. By Drug Release System
15.7.1.2.2. By Dosage Form
15.7.2. Indonesia Oral Controlled Release Drug Delivery Technology Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
15.7.2.2.1. By Drug Release System
15.7.2.2.2. By Dosage Form
15.7.3. Malaysia Oral Controlled Release Drug Delivery Technology Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
15.7.3.2.1. By Drug Release System
15.7.3.2.2. By Dosage Form
15.7.4. Thailand Oral Controlled Release Drug Delivery Technology Market Analysis
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast, by Market Taxonomy
15.7.4.2.1. By Drug Release System
15.7.4.2.2. By Dosage Form
16. Oceania Oral Controlled Release Drug Delivery Technology Market 2012-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Drug Release System
16.3.3. By Dosage Form
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug Release System
16.4.3. By Dosage Form
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Australia Oral Controlled Release Drug Delivery Technology Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
16.7.1.2.1. By Drug Release System
16.7.1.2.2. By Dosage Form
16.7.2. New Zealand Oral Controlled Release Drug Delivery Technology Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
16.7.2.2.1. By Drug Release System
16.7.2.2.2. By Dosage Form
17. Middle East and Africa (MEA) Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. South Africa
17.3.1.4. Israel
17.3.1.5. North Africa
17.3.1.6. Rest of Middle East and Africa
17.3.2. By Drug Release System
17.3.3. By Dosage Form
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug Release System
17.4.3. By Dosage Form
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country-Level Analysis & Forecast
17.7.1. GCC Countries Oral Controlled Release Drug Delivery Technology Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
17.7.1.2.1. By Drug Release System
17.7.1.2.2. By Dosage Form
17.7.2. Turkey Oral Controlled Release Drug Delivery Technology Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
17.7.2.2.1. By Drug Release System
17.7.2.2.2. By Dosage Form
17.7.3. South Africa Oral Controlled Release Drug Delivery Technology Market Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
17.7.3.2.1. By Drug Release System
17.7.3.2.2. By Dosage Form
17.7.4. Israel Oral Controlled Release Drug Delivery Technology Market Analysis
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast, by Market Taxonomy
17.7.4.2.1. By Drug Release System
17.7.4.2.2. By Dosage Form
17.7.5. North Africa Oral Controlled Release Drug Delivery Technology Market
17.7.5.1. Introduction
17.7.5.2. Market Analysis and Forecast, by Market Taxonomy
17.7.5.2.1. By Drug Release System
17.7.5.2.2. By Dosage Form
18. Market Structure Analysis
18.1. Market Analysis, by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. AstraZeneca Plc.
19.3.1.1. Overview
19.3.1.2. Drug Release System Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Key Financials
19.3.1.6. SWOT Analysis
19.3.1.7. Strategy Overview
19.3.2. Bristol-Myers Squibb Company
19.3.2.1. Overview
19.3.2.2. Drug Release System Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Key Financials
19.3.2.6. SWOT Analysis
19.3.2.7. Strategy Overview
19.3.3. Merck & Co. Inc.
19.3.3.1. Overview
19.3.3.2. Drug Release System Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Key Financials
19.3.3.6. SWOT Analysis
19.3.3.7. Strategy Overview
19.3.4. Novartis AG
19.3.4.1. Overview
19.3.4.2. Drug Release System Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Key Financials
19.3.4.6. SWOT Analysis
19.3.4.7. Strategy Overview
19.3.5. Pfizer Inc.
19.3.5.1. Overview
19.3.5.2. Drug Release System Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Key Financials
19.3.5.6. SWOT Analysis
19.3.5.7. Strategy Overview
19.3.6. F. Hoffman-La-Roche Ltd.
19.3.6.1. Overview
19.3.6.2. Drug Release System Portfolio
19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Key Financials
19.3.6.6. SWOT Analysis
19.3.6.7. Strategy Overview
19.3.7. Johnson & Johnson
19.3.7.1. Overview
19.3.7.2. Drug Release System Portfolio
19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Key Financials
19.3.7.6. SWOT Analysis
19.3.7.7. Strategy Overview
19.3.8. GlaxoSmithKline Plc.
19.3.8.1. Overview
19.3.8.2. Drug Release System Portfolio
19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Key Financials
19.3.8.6. SWOT Analysis
19.3.8.7. Strategy Overview
19.3.9. Sun Pharmaceuticals
19.3.9.1. Overview
19.3.9.2. Drug Release System Portfolio
19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
19.3.9.4. Sales Footprint
19.3.9.5. Key Financials
19.3.9.6. SWOT Analysis
19.3.9.7. Strategy Overview
19.3.10. Sanofi S.A.
19.3.10.1. Overview
19.3.10.2. Drug Release System Portfolio
19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
19.3.10.4. Sales Footprint
19.3.10.5. Key Financials
19.3.10.6. SWOT Analysis
19.3.10.7. Strategy Overview
19.3.11. Boehringer Ingelheim
19.3.11.1. Overview
19.3.11.2. Drug Release System Portfolio
19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
19.3.11.4. Sales Footprint
19.3.11.5. Key Financials
19.3.11.6. SWOT Analysis
19.3.11.7. Strategy Overview
19.3.12. AbbVie
19.3.12.1. Overview
19.3.12.2. Drug Release System Portfolio
19.3.12.3. Profitability by Market Segments (Product/Channel/Region)
19.3.12.4. Sales Footprint
19.3.12.5. Key Financials
19.3.12.6. SWOT Analysis
19.3.12.7. Strategy Overview
19.3.13. Takeda
19.3.13.1. Overview
19.3.13.2. Drug Release System Portfolio
19.3.13.3. Profitability by Market Segments (Product/Channel/Region)
19.3.13.4. Sales Footprint
19.3.13.5. Key Financials
19.3.13.6. SWOT Analysis
19.3.13.7. Strategy Overview
19.3.14. Eli Lilly
19.3.14.1. Overview
19.3.14.2. Drug Release System Portfolio
19.3.14.3. Profitability by Market Segments (Product/Channel/Region)
19.3.14.4. Sales Footprint
19.3.14.5. Key Financials
19.3.14.6. SWOT Analysis
19.3.14.7. Strategy Overview
19.3.15. Bayer
19.3.15.1. Overview
19.3.15.2. Drug Release System Portfolio
19.3.15.3. Profitability by Market Segments (Product/Channel/Region)
19.3.15.4. Sales Footprint
19.3.15.5. Key Financials
19.3.15.6. SWOT Analysis
19.3.15.7. Strategy Overview
19.3.16. Gilead Sciences
19.3.16.1. Overview
19.3.16.2. Drug Release System Portfolio
19.3.16.3. Profitability by Market Segments (Product/Channel/Region)
19.3.16.4. Sales Footprint
19.3.16.5. Key Financials
19.3.16.6. SWOT Analysis
19.3.16.7. Strategy Overview
19.3.17. Amgen
19.3.17.1. Overview
19.3.17.2. Drug Release System Portfolio
19.3.17.3. Profitability by Market Segments (Product/Channel/Region)
19.3.17.4. Sales Footprint
19.3.17.5. Key Financials
19.3.17.6. SWOT Analysis
19.3.17.7. Strategy Overview
19.3.18. BioNTech
19.3.18.1. Overview
19.3.18.2. Drug Release System Portfolio
19.3.18.3. Profitability by Market Segments (Product/Channel/Region)
19.3.18.4. Sales Footprint
19.3.18.5. Key Financials
19.3.18.6. SWOT Analysis
19.3.18.7. Strategy Overview
19.3.19. Viatris
19.3.19.1. Overview
19.3.19.2. Drug Release System Portfolio
19.3.19.3. Profitability by Market Segments (Product/Channel/Region)
19.3.19.4. Sales Footprint
19.3.19.5. Key Financials
19.3.19.6. SWOT Analysis
19.3.19.7. Strategy Overview
19.3.20. Moderna
19.3.20.1. Overview
19.3.20.2. Drug Release System Portfolio
19.3.20.3. Profitability by Market Segments (Product/Channel/Region)
19.3.20.4. Sales Footprint
19.3.20.5. Key Financials
19.3.20.6. SWOT Analysis
19.3.20.7. Strategy Overview
20. Assumptions and Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 02: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Table 03: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 by Region
Table 04: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 05: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 06: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Table 07: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 08: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 09: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Table 10: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 11: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 12: Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Table 13: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 14: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 15: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Table 16: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 17: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 18: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Table 19: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 20: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 21: Oceania Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032By Dosage Form
Table 22: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country
Table 23: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System
Table 24: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 02: Global Oral Controlled Release Drug Delivery Technology Market Forecast & Y-o-Y Growth 2022 to 2032
Figure 03: Global Oral Controlled Release Drug Delivery Technology Market Absolute $ Opportunity (US$ million) Analysis 2021 to 2032
Figure 04: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 By Drug Release System
Figure 05: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022 to 2032 By Drug Release System
Figure 06: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022 to 2032 By Drug Release System
Figure 07: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 By Dosage Form
Figure 08: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022 to 2032 By Dosage Form
Figure 09: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022 to 2032 By Dosage Form
Figure 10: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 by Region
Figure 11: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022 to 2032 by Region
Figure 12: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022 to 2032 by Region
Figure 13: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 14: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 15: North America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 16: North America Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 17: North America Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 18: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 19: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 20: USA Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 21: Global Vs. USA Growth Comparison 2022 to 2032
Figure 22: USA Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 23: U.S. Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 24: Canada Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 25: Global Vs. Canada. Growth Comparison 2022 to 2032
Figure 26: Canada Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 27: Canada Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 28: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 29: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 30: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 31: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 32: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 33: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 34: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032
Figure 35: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 36: Mexico Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 37: Global Vs Mexico Growth Comparison 2022 to 2032
Figure 38: Mexico Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 39: Mexico Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 40: Brazil Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 41: Global Vs. Brazil. Growth Comparison 2022 to 2032
Figure 42: Brazil Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 43: Brazil Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 44: Argentina Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 45: Global Vs Argentina Growth Comparison 2022 to 2032
Figure 46: Argentina Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 47: Argentina Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 48: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 49: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 50: Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 51: Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 52: Europe Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 53: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 54: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032
Figure 55: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 56: UK Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 57: Global Vs. UK Growth Comparison 2022 to 2032
Figure 58: UK Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 59: UK Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 60: Germany Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 61: Global Vs. Germany Growth Comparison 2022 to 2032
Figure 62: Germany Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 63: Germany Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 64: Italy Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 65: Global Vs. Italy Growth Comparison 2022 to 2032
Figure 66: Italy Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 67: Italy Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 68: France Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 69: Global Vs France Growth Comparison 2022 to 2032
Figure 70: France Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 71: France Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 72: Spain Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 73: Global Vs Spain Growth Comparison 2022 to 2032
Figure 74: Spain Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 75: Spain Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 76: Russia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 77: Global Vs Russia Growth Comparison 2022 to 2032
Figure 78: Russia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 79: Russia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 80: BENELUX Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 81: Global Vs BENELUX Growth Comparison 2022 to 2032
Figure 82: BENELUX Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 83: BENELUX Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 84: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 85: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 86: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 87: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 88: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 89: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 90: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032
Figure 91: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 92: China Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 93: Global Vs. China Growth Comparison 2022 to 2032
Figure 94: China Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 95: China Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 96: Japan Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 97: Global Vs. Japan Growth Comparison 2022 to 2032
Figure 98: Japan Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 99: Japan Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 100: South Korea Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 101: Global Vs South Korea Growth Comparison 2022 to 2032
Figure 102: South Korea Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 103: South Korea Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 104: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 105: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 106: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 107: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 108: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 109: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 110: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032
Figure 111: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 112: India Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 113: Global Vs. India Growth Comparison 2022 to 2032
Figure 114: India Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 115: India Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 116: Indonesia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 117: Global Vs. Indonesia Growth Comparison 2022 to 2032
Figure 118: Indonesia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 119: Indonesia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 120: Malaysia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 121: Global Vs. Malaysia Growth Comparison 2022 to 2032
Figure 122: Malaysia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 123: Malaysia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 124: Thailand Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 125: Global Vs. Thailand Growth Comparison 2022 to 2032
Figure 126: Thailand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 127: Thailand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 128: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 129: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 130: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 131: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 132: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 133: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 134: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032
Figure 135: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 136: Australia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 137: Global Vs. Australia Growth Comparison 2022 to 2032
Figure 138: Australia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 139: Australia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 140: New Zealand Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 141: Global Vs New Zealand Growth Comparison 2022 to 2032
Figure 142: New Zealand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 143: New Zealand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 144: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021
Figure 145: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032
Figure 146: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E)
Figure 147: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E)
Figure 148: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E)
Figure 149: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032
Figure 150: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032
Figure 151: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032
Figure 152: GCC Countries Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 153: Global Vs GCC Countries Growth Comparison 2022 to 2032
Figure 154: GCC Countries Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 155: GCC Countries Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 156: Turkey Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 157: Global Vs. Turkey Growth Comparison 2022 to 2032
Figure 158: Turkey Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 159: Turkey Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 160: South Africa Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 161: Global Vs. South Africa Growth Comparison 2022 to 2032
Figure 162: South Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 163: South Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Figure 164: North Africa Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021
Figure 165: Global Vs North Africa Growth Comparison 2022 to 2032
Figure 166: North Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032
Figure 167: North Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
